|
⚲
|
| Keyboard |
| Hart Daniel R
✚
|
|
|---|---|
| CIK # | 0001346342 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001346342] | |
| 4 | [0001346342] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Peregrine Pharmaceuticals Inc | |
| Hart Daniel R |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 104,000 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 2,938 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2025-02-05 | Disposed to issuer | 112,735 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 71,120 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 30,635 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 92,461 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 54,760 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 113,878 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-31 | Other | 1,755 | $6.05 | 10,618 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-26 | Sell | 20,845 | $12.22 | 254,726 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-26 | Sell | 1,968 | $12.22 | 24,049 |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-25 | Disposed to issuer | 4,279 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2025 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 22,818 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2024 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 11,304 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2024 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 11,303 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2023 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 11,208 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2023 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 11,208 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units (FY 2025 Grant) · derivative
|
2024-12-25 | Disposed to issuer | 22,817 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-25 | Option exercise | 4,279 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-25 | Option exercise | 45,328 | ||
| showing 20 of 136 most recent transactions | |||||